METTL16 and breast carcinoma: While METTL16 was initially recognized as an essential factor for mouse embryonic development by regulating Mat2a mRNA expression [21], subsequent evidence has shown the involvement of METTL16 in the progression of several cancers, including gastric cancer, hepatocellular carcinoma, and breast cancer [18, 24–26].